These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 16777648)

  • 1. Evaluating two group programmes of cognitive training in mild-to-moderate AD: is there any difference between a 'global' stimulation and a 'cognitive-specific' one?
    Farina E; Mantovani F; Fioravanti R; Pignatti R; Chiavari L; Imbornone E; Olivotto F; Alberoni M; Mariani C; Nemni R
    Aging Ment Health; 2006 May; 10(3):211-8. PubMed ID: 16777648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of recreational and occupational activities associated to psychologic support in mild to moderate Alzheimer disease: a multicenter controlled study.
    Farina E; Mantovani F; Fioravanti R; Rotella G; Villanelli F; Imbornone E; Olivotto F; Tincani M; Alberoni M; Petrone E; Nemni R; Postiglione A
    Alzheimer Dis Assoc Disord; 2006; 20(4):275-82. PubMed ID: 17132973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of galantamine on behavioural and psychological disturbances and caregiver burden in patients with Alzheimer's disease.
    Monsch AU; Giannakopoulos P;
    Curr Med Res Opin; 2004 Jun; 20(6):931-8. PubMed ID: 15200752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of a computer-based cognitive rehabilitation program on Alzheimer's disease patients compared with those on patients affected by mild cognitive impairment.
    Cipriani G; Bianchetti A; Trabucchi M
    Arch Gerontol Geriatr; 2006; 43(3):327-35. PubMed ID: 16451811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional dependence and caregiver burden in Alzheimer's disease: a controlled trial on the benefits of motor intervention.
    Canonici AP; Andrade LP; Gobbi S; Santos-Galduroz RF; Gobbi LT; Stella F
    Psychogeriatrics; 2012 Sep; 12(3):186-92. PubMed ID: 22994617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral disturbances in Alzheimer's disease: a non-pharmacological therapeutic approach.
    Silvestri A; Rosano G; Zannino G; Ricca F; Marigliano V; Fini M
    Arch Gerontol Geriatr Suppl; 2004; (9):379-86. PubMed ID: 15207436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 2-year open-label study of galantamine therapy in Chinese Alzheimer's disease patients in Hong Kong.
    Chu LW; Yik PY; Mok W; Chung CP
    Int J Clin Pract; 2007 Mar; 61(3):403-10. PubMed ID: 17313606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cognitive treatment of Alzheimer's disease: a single case study.
    Fernández AL; Manoiloff LM; Monti AA
    Neuropsychol Rehabil; 2006 Feb; 16(1):96-109. PubMed ID: 16509521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caregivers' estimation of patients' quality of life (QoL) in Alzheimer's disease (AD): an approach using the ADRQL.
    León-Salas B; Olazarán J; Muñiz R; González-Salvador MT; Martínez-Martín P
    Arch Gerontol Geriatr; 2011; 53(1):13-8. PubMed ID: 20573409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do patients diagnosed with Alzheimer's disease benefit from a psycho-educational programme for family caregivers? A randomised controlled study.
    de Rotrou J; Cantegreil I; Faucounau V; Wenisch E; Chausson C; Jegou D; Grabar S; Rigaud AS
    Int J Geriatr Psychiatry; 2011 Aug; 26(8):833-42. PubMed ID: 20922772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial.
    Scheltens P; Kamphuis PJ; Verhey FR; Olde Rikkert MG; Wurtman RJ; Wilkinson D; Twisk JW; Kurz A
    Alzheimers Dement; 2010 Jan; 6(1):1-10.e1. PubMed ID: 20129316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.
    Rozzini L; Costardi D; Chilovi BV; Franzoni S; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):356-60. PubMed ID: 17117398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
    Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
    Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
    Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
    Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.